03:51 PM EST - Ondine Biopharma Corp. : said its fourth-quarter loss narrowed to $1.23 million from $2.12 million a year ago. Loss per common share for the latest quarter also reduced to $0.01 from $0.03 in the prior year. Revenue for the quarter increased to $249,000 from $138,000 in the previous year. Product sales for the fourth quarter of 2009 plummeted to $39,000 from $302,000 in the year-earlier period. Ondine Biopharma Corp.
shares T.OBP are trading even at $0.08.
